Sofosbuvir
Showing 1 - 25 of 431
HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)
Recruiting
- HCV
- Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
-
Cairo, EgyptFaculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)
Recruiting
- Hepatitis C, Chronic
- Pregnancy; Infection
- Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
-
Denver, Colorado
- +4 more
Dec 3, 2022
Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir
Not yet recruiting
- Hepatitis C Infection
-
Beijing, Bejing, ChinaBejing Tsinghua Changgung Hospital
Oct 31, 2022
Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
- Cardiac MRI
-
Washington, District of Columbia
- +1 more
Feb 1, 2023
Sofosbuvir/Daclatasvir in HCV-infected Lactating Women
Recruiting
- Hepatitis C Virus Infection
- Pharmacokinetic test
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Aug 21, 2022
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)
Completed
- Chronic Hepatitis c Genotype 1
- Narlaprevir
- +2 more
-
Moscow, Russian Federation
- +4 more
Oct 27, 2022
HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)
Not yet recruiting
- HCV Infection
-
Phnom Penh, CambodiaClinical Trial Unit (Ctu)
Aug 7, 2023
Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)
Active, not recruiting
- Liver Transplant
- Hepatitis C
-
Pittsburgh, PennsylvaniaUPMC
Oct 6, 2022
Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))
Recruiting
- Hepatitis C
- Sofosbuvir 400mg [Sovaldi]
- Glecaprevir/pibrentasvir (300mg/120mg)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 28, 2022
HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],
Completed
- HCV Coinfection
- +2 more
- Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
- Sofosbuvir/Velpatasvir (SOF/VEL)
-
Baltimore, MarylandJohns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022
Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)
Completed
- Hepatitis C, Chronic
- Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
-
Mansoura, EgyptMansoura University Children Hospital
Oct 21, 2021
Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],
Completed
- Hepatitis B
- Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
- +2 more
-
Baltimore, MarylandInstitute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021
Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)
Recruiting
- Hepatitis C
- Awaiting Organ Transplant
- Sofosbuvir/velpatasvir
- Monitoring
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 14, 2022
Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)
Completed
- Covid19
- SARS-CoV Infection
-
Johannesburg, Gauteng, South Africa
- +1 more
Jun 6, 2022
Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)
Recruiting
- Hepatitis C, Chronic
- Sofosbuvir-Velpatasvir Drug Combination
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh, Magee Womens Hospital
Sep 3, 2021
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)
Recruiting
- Male Infertility
- HCV
- Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
-
Al Qalyūbīyah, Benha, Egypt
- +1 more
Nov 7, 2022
Elimination of Hepatitis C Virus Among Users of Substances
Not yet recruiting
- Hepatitis C in Substance Users
- Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
- (no location specified)
Aug 14, 2022
Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or
Active, not recruiting
- Chronic Hepatitis C
- People Who Inject Drugs
- velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
-
Atlanta, GeorgiaWellstar Atlanta Medical Center
May 31, 2023
Hepatitis C Treatment Study in Myanmar
Withdrawn
- Hepatitis C
- Sofosbuvir 400 mg
-
Yangon, MyanmarMedical Action Myanmar
Dec 3, 2021
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Kidney Transplantation, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)
Active, not recruiting
- Kidney Transplantation
- Hepatitis C
-
Pittsburgh, PennsylvaniaUPMC
Oct 27, 2021
Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)
Recruiting
- Hepatitis C
- HCV RNA Point of Care
- +2 more
-
Sydney, New South Wales, AustraliaNUAA NSP
Aug 19, 2022